Stephanie Carlsen, APRN
Adult Health · Reno, NVNPI 1750769964
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,538 of the $9,274 with a category attached, or 70.5%. Edwards Lifesciences accounts for 65.3% of it on its own, with 16 other manufacturers making up the rest. Among adult health clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $36.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$6K
- Abbott$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$280
- Boston Scientific$153
- Bridgebio Pharma, Inc.$138
- Novartis$80
- plus $375 from 11 others
What the payments were for
- Travel & lodging$2,73529%
- Food & beverage$6,53870%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 176 | $6,057 |
| Abbott | 48 | $2,192 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $280 |
| Boston Scientific | 4 | $153 |
| Bridgebio Pharma, Inc. | 1 | $138 |
| Novartis | 4 | $80 |
| Boehringer Ingelheim | 3 | $67 |
| Johnson & Johnson | 4 | $66 |
| Merck | 2 | $44 |
| Scpharmaceuticals Inc. | 2 | $43 |
| Heartflow, Inc. | 1 | $30 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,274 in reported general payments places this provider in the 90th percentile of 90 adult health providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 266 | $352,418 |
| XareltoRivaroxaban | 123 | $136,231 |
| JardianceEmpagliflozin | 52 | $74,553 |
| FarxigaDapagliflozin Propanediol | 45 | $47,682 |
| EntrestoSacubitril/Valsartan | 25 | $38,051 |
| Praluent PenAlirocumab | 46 | $32,589 |
| Repatha SureclickEvolocumab | 29 | $28,173 |
| Repatha SyringeEvolocumab | 13 | $11,136 |
| Atorvastatin Calcium | 472 | $10,740 |
| Metoprolol Succinate | 542 | $9,067 |
| Rosuvastatin Calcium | 319 | $6,917 |
| Ezetimibe | 123 | $6,831 |
| Losartan Potassium | 301 | $4,734 |
| Potassium Chloride | 146 | $3,950 |
| Carvedilol | 155 | $3,593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $66 | $136,231123 claims |
| Boehringer IngelheimJardiance | $67 | $74,55352 claims |
| NovartisEntresto | $80 | $38,05125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 adult health providers in Nevada.
Other adult health in Reno
- Madhu Dewan KhatriReno$7K
- Rommel CoReno$6K
- Samantha PotencianoReno$3K
- Edin AbdagicReno$3K
- Lindsay ByrneReno$2K
- Valerie JakubosReno$1K
- Brittany BeaumierReno$1K
- Renee HinojosaReno$1K
- Hector JoseReno$956
- Jessica WilkinsonReno$867
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.